187 related articles for article (PubMed ID: 11429217)
1. Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta.
Fu XL; Huang H; Bentel G; Clough R; Jirtle RL; Kong FM; Marks LB; Anscher MS
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):899-908. PubMed ID: 11429217
[TBL] [Abstract][Full Text] [Related]
2. Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis.
Anscher MS; Kong FM; Andrews K; Clough R; Marks LB; Bentel G; Jirtle RL
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1029-35. PubMed ID: 9719112
[TBL] [Abstract][Full Text] [Related]
3. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
[TBL] [Abstract][Full Text] [Related]
4. Cytokine profiling for prediction of symptomatic radiation-induced lung injury.
Hart JP; Broadwater G; Rabbani Z; Moeller BJ; Clough R; Huang D; Sempowski GA; Dewhirst M; Pizzo SV; Vujaskovic Z; Anscher MS
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1448-54. PubMed ID: 16115739
[TBL] [Abstract][Full Text] [Related]
5. Plasma transforming growth factor-beta1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma.
Kong F; Jirtle RL; Huang DH; Clough RW; Anscher MS
Cancer; 1999 Nov; 86(9):1712-9. PubMed ID: 10547543
[TBL] [Abstract][Full Text] [Related]
6. Changes in plasma TGF beta levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis.
Anscher MS; Murase T; Prescott DM; Marks LB; Reisenbichler H; Bentel GC; Spencer D; Sherouse G; Jirtle RL
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):671-6. PubMed ID: 7928499
[TBL] [Abstract][Full Text] [Related]
7. Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation.
Anscher MS; Marks LB; Shafman TD; Clough R; Huang H; Tisch A; Munley M; Herndon JE; Garst J; Crawford J; Jirtle RL
J Clin Oncol; 2001 Sep; 19(17):3758-65. PubMed ID: 11533099
[TBL] [Abstract][Full Text] [Related]
8. Risk of long-term complications after TFG-beta1-guided very-high-dose thoracic radiotherapy.
Anscher MS; Marks LB; Shafman TD; Clough R; Huang H; Tisch A; Munley M; Herndon JE; Garst J; Crawford J; Jirtle RL
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):988-95. PubMed ID: 12829134
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients.
Novakova-Jiresova A; Van Gameren MM; Coppes RP; Kampinga HH; Groen HJ
Radiother Oncol; 2004 May; 71(2):183-9. PubMed ID: 15110452
[TBL] [Abstract][Full Text] [Related]
10. Effects of rhubarb extract on radiation induced lung toxicity via decreasing transforming growth factor-beta-1 and interleukin-6 in lung cancer patients treated with radiotherapy.
Yu HM; Liu YF; Cheng YF; Hu LK; Hou M
Lung Cancer; 2008 Feb; 59(2):219-26. PubMed ID: 17870203
[TBL] [Abstract][Full Text] [Related]
11. Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis.
Anscher MS; Kong FM; Marks LB; Bentel GC; Jirtle RL
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):253-8. PubMed ID: 9069294
[TBL] [Abstract][Full Text] [Related]
12. Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy.
Stenmark MH; Cai XW; Shedden K; Hayman JA; Yuan S; Ritter T; Ten Haken RK; Lawrence TS; Kong FM
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e217-22. PubMed ID: 22935395
[TBL] [Abstract][Full Text] [Related]
13. The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer.
Zhao L; Sheldon K; Chen M; Yin MS; Hayman JA; Kalemkerian GP; Arenberg D; Lyons SE; Curtis JL; Davis M; Cease KB; Brenner D; Anscher MS; Lawrence TS; Kong FM
Lung Cancer; 2008 Feb; 59(2):232-9. PubMed ID: 17905467
[TBL] [Abstract][Full Text] [Related]
14. [Relationship of dose-volume histogram parameters and computed tomography grading of radiation-induced lung injury in patients with non-small cell lung cancer treated by three-dimensional conformal radiotherapy].
Xing J; Li JB; Yu JM; Lu J; Xu M; Fan TY; Shao Q; Guo SF
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):676-81. PubMed ID: 19173909
[TBL] [Abstract][Full Text] [Related]
15. Genetic variations in TGFβ1, tPA, and ACE and radiation-induced thoracic toxicities in patients with non-small-cell lung cancer.
Yuan ST; Ellingrod VL; Schipper M; Stringer KA; Cai X; Hayman JA; Yu J; Lawrence TS; Kong FM
J Thorac Oncol; 2013 Feb; 8(2):208-13. PubMed ID: 23334061
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury.
Kong FM; Anscher MS; Sporn TA; Washington MK; Clough R; Barcellos-Hoff MH; Jirtle RL
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):35-41. PubMed ID: 11163495
[TBL] [Abstract][Full Text] [Related]
17. Physical and biological predictors of changes in whole-lung function following thoracic irradiation.
Marks LB; Munley MT; Bentel GC; Zhou SM; Hollis D; Scarfone C; Sibley GS; Kong FM; Jirtle R; Jaszczak R; Coleman RE; Tapson V; Anscher M
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):563-70. PubMed ID: 9336133
[TBL] [Abstract][Full Text] [Related]
18. Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan.
Zhao L; Wang L; Ji W; Wang X; Zhu X; Hayman JA; Kalemkerian GP; Yang W; Brenner D; Lawrence TS; Kong FM
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1385-90. PubMed ID: 19231104
[TBL] [Abstract][Full Text] [Related]
19. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
[TBL] [Abstract][Full Text] [Related]
20. [Correlation study of physical and biologic parameters to acute radiation pneumonitis].
Zhao YH; Li ZP; Chen XM; Liu XJ; Wu WC; Xu Y; Li P; Zhang JT; Zeng H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):796-800. PubMed ID: 19024317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
